90 related articles for article (PubMed ID: 28972092)
21. Regulatory B10 cell development and function.
Lykken JM; Candando KM; Tedder TF
Int Immunol; 2015 Oct; 27(10):471-7. PubMed ID: 26254185
[TBL] [Abstract][Full Text] [Related]
22. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
23. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus.
Jones SA; Toh AE; Odobasic D; Oudin MA; Cheng Q; Lee JP; White SJ; Russ BE; Infantino S; Light A; Tarlinton DM; Harris J; Morand EF
Ann Rheum Dis; 2016 Apr; 75(4):739-47. PubMed ID: 26612340
[TBL] [Abstract][Full Text] [Related]
24. Identifying regulatory B cells (B10 cells) that produce IL-10 in mice.
Matsushita T; Tedder TF
Methods Mol Biol; 2011; 677():99-111. PubMed ID: 20941605
[TBL] [Abstract][Full Text] [Related]
25. Concordance of increased B1 cell subset and lupus phenotypes in mice and humans is dependent on BLK expression levels.
Wu YY; Georg I; Díaz-Barreiro A; Varela N; Lauwerys B; Kumar R; Bagavant H; Castillo-Martín M; El Salem F; Marañón C; Alarcón-Riquelme ME
J Immunol; 2015 Jun; 194(12):5692-702. PubMed ID: 25972485
[TBL] [Abstract][Full Text] [Related]
26. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease.
Kalampokis I; Yoshizaki A; Tedder TF
Arthritis Res Ther; 2013; 15 Suppl 1(Suppl 1):S1. PubMed ID: 23566714
[TBL] [Abstract][Full Text] [Related]
27. Effects of Wiskott-Aldrich Syndrome Protein Deficiency on IL-10-Producing Regulatory B Cells in Humans and Mice.
Du HQ; Zhang X; An YF; Ding Y; Zhao XD
Scand J Immunol; 2015 Jun; 81(6):483-93. PubMed ID: 25728049
[TBL] [Abstract][Full Text] [Related]
28. ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis.
Aragoneses-Fenoll L; Montes-Casado M; Ojeda G; Acosta YY; Herranz J; Martínez S; Blanco-Aparicio C; Criado G; Pastor J; Dianzani U; Portolés P; Rojo JM
Biochem Pharmacol; 2016 Apr; 106():56-69. PubMed ID: 26883061
[TBL] [Abstract][Full Text] [Related]
29. Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression.
Sungalee S; Mamessier E; Morgado E; Grégoire E; Brohawn PZ; Morehouse CA; Jouve N; Monvoisin C; Menard C; Debroas G; Faroudi M; Mechin V; Navarro JM; Drevet C; Eberle FC; Chasson L; Baudimont F; Mancini SJ; Tellier J; Picquenot JM; Kelly R; Vineis P; Ruminy P; Chetaille B; Jaffe ES; Schiff C; Hardwigsen J; Tice DA; Higgs BW; Tarte K; Nadel B; Roulland S
J Clin Invest; 2014 Dec; 124(12):5337-51. PubMed ID: 25384217
[TBL] [Abstract][Full Text] [Related]
30. The Role of CD38 on the Function of Regulatory B Cells in a Murine Model of Lupus.
Burlock B; Richardson G; García-Rodríguez S; Guerrero S; Zubiaur M; Sancho J
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257456
[TBL] [Abstract][Full Text] [Related]
31. Suboptimal B-cell antigen receptor signaling activity in vivo elicits germinal center counterselection mechanisms.
Königsberger S; Weis V; Prodöhl J; Stehling M; Hobeika E; Reth M; Kiefer F
Eur J Immunol; 2015 Feb; 45(2):603-11. PubMed ID: 25382621
[TBL] [Abstract][Full Text] [Related]
32. IL-10 derived from CD1dhiCD5⁺ B cells regulates experimental autoimmune myasthenia gravis.
Sheng JR; Quan S; Soliven B
J Neuroimmunol; 2015 Dec; 289():130-8. PubMed ID: 26616882
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P
J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531
[TBL] [Abstract][Full Text] [Related]
34. A20 expression in dendritic cells protects mice from LPS-induced mortality.
Xuan NT; Wang X; Nishanth G; Waisman A; Borucki K; Isermann B; Naumann M; Deckert M; Schlüter D
Eur J Immunol; 2015 Mar; 45(3):818-28. PubMed ID: 25472594
[TBL] [Abstract][Full Text] [Related]
35. Curiouser and curiouser: the role(s) of AID expression in self-tolerance.
Kelsoe G
Eur J Immunol; 2014 Oct; 44(10):2876-9. PubMed ID: 25308427
[TBL] [Abstract][Full Text] [Related]
36. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
[TBL] [Abstract][Full Text] [Related]
37. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
38. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
[TBL] [Abstract][Full Text] [Related]
39. Bim suppresses the development of SLE by limiting myeloid inflammatory responses.
Tsai F; Homan PJ; Agrawal H; Misharin AV; Abdala-Valencia H; Haines GK; Dominguez S; Bloomfield CL; Saber R; Chang A; Mohan C; Hutcheson J; Davidson A; Budinger GRS; Bouillet P; Dorfleutner A; Stehlik C; Winter DR; Cuda CM; Perlman H
J Exp Med; 2017 Dec; 214(12):3753-3773. PubMed ID: 29114065
[TBL] [Abstract][Full Text] [Related]
40. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
